Palliative treatment of patients with inoperable locally advanced, recurrent or metastatic head and neck squamous cell cancer, using a low-dose and personalized chemotherapeutic regimen

Inoperable or metastatic head and neck squamous cell cancer (HNSCC) is known to be associated with a poor patient prognosis. First line therapies include a Taxol, platinum-based antineoplastic and fluorouracil (FU) treatment regimen (TPF) or a platinum-based antineoplastic, FU and EGFR inhibitor tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Bishnoi, Rohit, Bennett, Jeffery, Reisman, David N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452905/
https://www.ncbi.nlm.nih.gov/pubmed/28588721
http://dx.doi.org/10.3892/ol.2017.6068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452905/
https://www.ncbi.nlm.nih.gov/pubmed/28588721
http://dx.doi.org/10.3892/ol.2017.6068

Ejemplares similares